The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human
Open accessAbstract
Opioid agonists are the most effective treatment for pain, but their use is limited by side effects, tolerance and fears of addiction and dependence. A major goal of opioid research is to develop agonists that have high analgesic efficacy and a low profile for side effects, tolerance, addiction and dependence. Unfortunately, there is a serious lack of experimental data comparing the degree to which different opioids produce these effects in humans. In contrast, a wide range of experimental techniques from heterologous expression systems to behaviour assessment in whole animals have been developed to study these problems. The objective of this review is to describe and evaluate these techniques as they are used to study opioid efficacy, tolerance, addiction and dependence. LINKED ARTICLES This article is part of a themed issue on Translational Neuropharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐4
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex, gender, and pain: a review of recent clinical and experimental findings
Fillingim, R. B., King, C. D., Ribeiro-Dasilva, M. C., Rahim-Williams, B., & Riley, J. L. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.12.001 · Cited by 2,766
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
McMahon, F. G. (1986) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1986.35.673 · Cited by 2,215
Rácz, I., & Zimmer, A. (2006) · Standards of Mouse Model Phenotyping · doi:10.1002/9783527611942.ch9 · Cited by 1,659
Meta‐analysis of cue‐reactivity in addiction research
Carter, B. L., & Tiffany, S. T. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9433273.x · Cited by 1,638 · cited 2×
“A major problem with inpatient treatment programmes for drug addiction is relapse when the person returns to the ‘drug’ environment (Carter and Tiffany, 1999).”
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
Le Bars, D., Gozariu, M., & Cadden, S. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01514-x · Cited by 1,459
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Richardson, N. R., & Roberts, D. C. S. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(95)00153-0 · Cited by 1,358
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,241
Molecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Self-citationMolecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Long-term opioid management for chronic noncancer pain
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C., Schoelles, K. M., & Chou, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006605.pub2 · Cited by 735
Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00197-3 · Cited by 656
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620
McBride, W. J., Murphy, J. M., & Ikemoto, S. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00022-4 · Cited by 574
Clinical Pharmacology of Opioids for Pain
Inturrisi, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200207001-00002 · Cited by 571
How opioids inhibit GABA-mediated neurotransmission
Vaughan, C. W., Ingram, S. L., Connor, M. A., & Christie, M. J. (1997) · Nature · doi:10.1038/37610 · Cited by 507
Self-citationContext-induced relapse to drug seeking: a review
Crombag, H. S., Bossert, J. M., Koya, E., & Shaham, Y. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0090 · Cited by 495
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
Christie, M. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.100 · Cited by 478
Self-citationLett, B. T. (1989) · Psychopharmacology · doi:10.1007/bf00451687 · Cited by 477
Traynor, J. R., & Nahorski, S. R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08634-1 · Cited by 462
Opioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
Functional Dissociation of μ Opioid Receptor Signaling and Endocytosis
Whistler, J. L., Chuang, H.-H., Chu, P., Jan, L. Y., & von Zastrow, M. (1999) · Neuron · doi:10.1016/s0896-6273(01)80032-5 · Cited by 413
Eisenberg, E., McNicol, E. D., & Carr, D. B. (2005) · JAMA · doi:10.1001/jama.293.24.3043 · Cited by 407
Tobias, J. D. (2000) · Critical Care Medicine · doi:10.1097/00003246-200006000-00079 · Cited by 401
Buprenorphine induces ceiling in respiratory depression but not in analgesia
Dahan, A., Yassen, A., Romberg, R., Sarton, E., Teppema, L., Olofsen, E., & Danhof, M. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael051 · Cited by 376
Przewłocki, R., & Przewłocka, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01308-5 · Cited by 367
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 359
Drug Abuse, Dependence, and Addiction in Chronic Pain Patients
Fishbain, D. A., Rosomoff, H. L., & Rosomoff, R. S. (1992) · The Clinical Journal of Pain · doi:10.1097/00002508-199206000-00003 · Cited by 357
Keith, D. E., Antón, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & von Zastrow, M. (1998) · PubMed · Cited by 317
Lu, L., Shepard, J. D., Scott Hall, F., & Shaham, Y. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00073-3 · Cited by 276
Keith, D. E., Anton, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & Zastrow, M. V. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.377 · Cited by 276
Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications
Bossert, J. M., Ghitza, U. E., Lu, L., Epstein, D. H., & Shaham, Y. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.030 · Cited by 271
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270
Cellular mechanisms of opioid tolerance: studies in single brain neurons.
Christie, M. J., Williams, J. T., & North, R. A. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13048-4 · Cited by 264
Self-citationMcPherson, J., Rivero, G., Baptist, M., Llorente, J., Al-Sabah, S., Krasel, C., Dewey, W. L., Bailey, C. P., Rosethorne, E. M., Charlton, S. J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066613 · Cited by 262
Clinical and laboratory assessment of the subjective experience of drug craving
Rosenberg, H. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.06.002 · Cited by 251
Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen, Y., Mestek, A., Liu, J., et al. (1993) · PubMed · Cited by 243
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
The Effect of Intrinsic Efficacy on Opioid Tolerance
Duttaroy, A., & Yoburn, B. C. (1995) · Anesthesiology · doi:10.1097/00000542-199505000-00018 · Cited by 214
Opioid tolerance: the clinical perspective
Collett, B. J. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.58 · Cited by 207
Mitrovic, I., Margeta-Mitrovic, M., Bader, S., Stoffel, M., Jan, L. Y., & Basbaum, A. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136822100 · Cited by 204
DEVELOPMENT AND LOSS OF TOLERANCE TO MORPHINE IN THE RAT AFTER SINGLE AND MULTIPLE INJECTIONS
Cochin, J., & Kornetsky, C. (1964) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26815-x · Cited by 201
Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study
Portenoy, R. K., Farrar, J. T., Backonja, M.-M., Cleeland, C. S., Yang, K., Friedman, M., Colucci, S. V., & Richards, P. (2007) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31802b582f · Cited by 200
Prescription Drug Abuse: Insight Into the Epidemic
Hernandez, S. H., & Nelson, L. S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.154 · Cited by 183
Drug abuse potential evaluation in animals
BALSTER, R. L. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01747.x · Cited by 179
Alvarez, V. A., Arttamangkul, S., Dang, V., Salem, A., Whistler, J. L., von Zastrow, M., Grandy, D. K., & Williams, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05769.2002 · Cited by 170
Cook, C. D., Barrett, A. C., Roach, E. L., Bowman, J. R., & Picker, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000453 · Cited by 167
Do Opioids Induce Hyperalgesia in Humans? An Evidence-Based Structured Review
Fishbain, D. A., Cole, B., Lewis, J. E., Gao, J., & Rosomoff, R. S. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00653.x · Cited by 167
Receptor Endocytosis Counteracts the Development of Opioid Tolerance
Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L.-O., Wundrack, N., Beyer, A., Grecksch, G., & Höllt, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004994 · Cited by 167
Selley, D. E., Liu, Q., & Childers, S. R. (1998) · PubMed · Cited by 167
Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers
Comer, S. D., Sullivan, M. A., Whittington, R. A., Vosburg, S. K., & Kowalczyk, W. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301479 · Cited by 165
Borgland, S. L., Connor, M., Osborne, P. B., Furness, J. B., & Christie, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300525200 · Cited by 165
Self-citationTrafton, J. A., Abbadie, C., Marek, K. W., & Basbaum, A. I. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08578.2000 · Cited by 154
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
Melief, E. J., Miyatake, M., Bruchas, M. R., & Chavkin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000751107 · Cited by 154
The role of human drug self-administration procedures in the development of medications
Comer, S. D., Ashworth, J., Foltin, R. W., Johanson, C. E., Zacny, J. P., & WALSH, S. L. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.001 · Cited by 154
Johanson, C. E., & Balster, R. L. (1978) · PubMed · Cited by 152
Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal Neurons
Haberstock-Debic, H., Kim, K., Yu, Y., & von Zastrow, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5045-04.2005 · Cited by 148
Second-order schedules of drug self-administration in animals
Schindler, C. W., Panlilio, L. V., & Goldberg, S. R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1157-4 · Cited by 146
The Influence of Non-Nociceptive Factors on Hot-Plate Latency in Rats
Gunn, A., Bobeck, E. N., Weber, C. J., & Morgan, M. M. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.06.011 · Cited by 143
Self-citationSelf‐administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls
Haney, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00121.x · Cited by 142
Kovoor, A., Celver, J. P., Wu, A., & Chavkin, C. (1998) · PubMed · Cited by 135
Adams, J. U., Paronis, C. A., & Holtzman, S. G. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23036-1 · Cited by 133
Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?
Zaki, P. A., Keith, D. E., Brine, G. A., Carroll, F. I., & Evans, C. J. (2000) · PubMed · Cited by 129
Stevens, C. W., & Yaksh, T. L. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21323-4 · Cited by 128
Heterologous expression of G-protein-coupled receptors
Tate, C. G., & Grisshammer, R. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)10059-7 · Cited by 126
Acute Opioid Receptor Desensitization And Tolerance: Is There A Link?
Borgland, S. L. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03418.x · Cited by 125
The pharmacological treatment of opioid addiction—a clinical perspective
Lobmaier, P. P. K., Gossop, M., Waal, H., & Bramness, J. G. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0793-6 · Cited by 125
Agonist binding, agonist affinity and agonist efficacy at G protein‐coupled receptors
Strange, P. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707672 · Cited by 119
Yuferov, V. P., Levran, O., Proudnikov, D., Nielsen, D. A., & Kreek, M. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05275.x · Cited by 117
Zhou, D., Chen, M.-L., Zhang, Y.-Q., & Zhao, Z.-Q. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5377-09.2010 · Cited by 114
Differential Activation and Trafficking of μ-Opioid Receptors in Brain Slices
Arttamangkul, S., Quillinan, N., Low, M. J., von Zastrow, M., Pintar, J. E., & Williams, J. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048512 · Cited by 112
Sites of action of morphine involved in the development of physical dependence in rats
Laschka, E., Teschemacher, H., Mehraein, P., & Herz, A. (1976) · Psychopharmacology · doi:10.1007/bf00421383 · Cited by 110
Law, P., Erickson, L. J., Kouhen, R. E., Dicker, L. H., Solberg, J. C., Wang, W., Miller, E., Burd, A. L., & Loh, H. H. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12075-5 · Cited by 109
Wilson, S. G., Smith, S. B., Chesler, E. J., Melton, K. A., Haas, J. J., Mitton, B. A., Strasburg, K., Hubert, L. J., Rodriguez‐Zas, S. L., & Mogil, J. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041889 · Cited by 107
Vera–Portocarrero, L. P., Zhang, E.-T., King, T. E., Ossipov, M. H., Vanderah, T. W., Lai, J. Y., & Porreca, F. (2006) · Pain · doi:10.1016/j.pain.2006.09.033 · Cited by 107
Age-Dependent Opioid Escalation in Chronic Pain Patients
Buntin-Mushock, C., Phillip, L., Moriyama, K., & Pierce, P. A. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000152191.29311.9b · Cited by 104
Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids.
Craft, R. M. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0012931 · Cited by 104
Differential Cross-tolerance Between Intrathecal Morphine and Sufentanil in the Rat
Sosnowski, M., & Yaksh, T. L. (1990) · Anesthesiology · doi:10.1097/00000542-199012000-00012 · Cited by 101
Pharmacogenetic analysis of sex differences in opioid antinociception in rats
Terner, J. M., Lomas, L. M., Smith, E. S., Barrett, A. C., & Picker, M. J. (2003) · Pain · doi:10.1016/j.pain.2003.08.008 · Cited by 99
Distinct Domains of the μ-Opioid Receptor Control Uncoupling and Internalization
Celver, J. P., Xu, M., Jin, W., Lowe, J., & Chavkin, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.528 · Cited by 98
Cellular Actions Of Opioids And Other Analgesics: Implications For Synergism In Pain Relief
Christie, M. J., Connor, M. A., Vaughan, C. W., Ingram, S., & Bagley, E. E. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03291.x · Cited by 90
Self-citationLong-term opioid management for chronic noncancer pain
Noble, M., Treadwell, J. R., Tregear, S., Coates, V. H., Wiffen, P. J., Akafomo, C., & Schoelles, K. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006605 · Cited by 90
Detoxification of Rehabilitated Methadone-Maintained Patients
Cushman, P. (1973) · JAMA · doi:10.1001/jama.1973.03230070013002 · Cited by 88
Self-administration of morphine in bone marrow transplant patients reduces drug requirement
Hill, H. F., Chapman, R. C., Kornell, J. A., Sullivan, K. M., Saeger, L. C., & Benedetti, C. (1990) · Pain · doi:10.1016/0304-3959(90)90062-i · Cited by 85
Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons
Macey, T. A., Lowe, J., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604278200 · Cited by 84
Mathews, J. L., Smrcka, A. V., & Bidlack, J. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2326-08.2008 · Cited by 82
Differential activation of G‐proteins byμ‐opioid receptor agonists
Saidak, Z., Blake-Palmer, K. G., Hay, D. L., Northup, J. K., & Glass, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706661 · Cited by 81
Walker, E. A., & Young, A. M. (2001) · Psychopharmacology · doi:10.1007/s002130000620 · Cited by 78
Single-trial conditioned place preference using intravenous morphine
Bardo, M. T., & Neisewander, J. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90092-4 · Cited by 78
Morphine Antinociceptive Potency on Chemical, Mechanical, and Thermal Nociceptive Tests in the Rat
Morgan, M. M., Bobeck, E. N., Stalding, B. M., & King, M. M. (2006) · Journal of Pain · doi:10.1016/j.jpain.2005.12.009 · Cited by 76
Self-citationHull, L. C., Llorente, J., Gabra, B. H., Smith, F. L., Kelly, E., Bailey, C. P., Henderson, G., & Dewey, W. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161455 · Cited by 73
Zeng, J., Thomson, L. M., Aicher, S. A., & Terman, G. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2530-06.2006 · Cited by 72
Some new insights into the effects of opioids in phasic and tonic nociceptive tests
McCormack, K., Prather, P. L., & Chapleo, C. B. (1998) · Pain · doi:10.1016/s0304-3959(98)00146-8 · Cited by 72
Morgan, M. M., FOSSUM, E., LEVINE, C., & Ingram, S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.08.003 · Cited by 69
Self-citationWerz, M. A., & Macdonald, R. L. (1982) · Brain Research · doi:10.1016/0006-8993(82)90859-9 · Cited by 69
Aley, K. O., & Levine, J. D. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-08018.1997 · Cited by 66
How to design an opioid drug that causes reduced tolerance and dependence
Berger, A. C., & Whistler, J. L. (2010) · Annals of Neurology · doi:10.1002/ana.22002 · Cited by 65
Buprenorphine: Demonstration of physical dependence liability
Dum, J., Bläsig, J., & Herz, A. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90163-1 · Cited by 61
Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in Vivo
Patel, M. B., Patel, C. N., Rajashekara, V., & Yoburn, B. C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1464 · Cited by 60
Morphine-Induced μ-Opioid Receptor Desensitization
Dang, V. C., & Williams, J. T. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013185 · Cited by 59
Animal models for assessing drugs of abuse
Brady, J. V. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80089-2 · Cited by 57
Pawar, M., Kumar, P., Sunkaraneni, S., SIROHI, S. K., Walker, E. A., & Yoburn, B. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.059 · Cited by 56
Stevens, C. W., & Yaksh, T. L. (1990) · Survey of Anesthesiology · doi:10.1097/00132586-199010000-00036 · Cited by 56
Sittl, R., Nuijten, M. J. C., & Nautrup, B. P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.002 · Cited by 56
Winger, G. D., & Woods, J. H. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00166-6 · Cited by 51
Narita, M., Ioka, M., Suzuki, M., Narita, M., & Suzuki, T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00141-6 · Cited by 49
In vivo apparent affinity and efficacy estimates for ? opiates in a rat tail-withdrawal assay
Zernig, G., Young, A. M., & Walker, E. A. (1998) · Psychopharmacology · doi:10.1007/s002130050534 · Cited by 49
Macey, T. A., Bobeck, E. N., Hegarty, D. M., Aicher, S. A., Ingram, S., & Morgan, M. M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152157 · Cited by 47
Self-citationReceptor-selective antagonism of opioid antinociception in female versus male rats
Craft, R. M., Tseng, A. H., McNiel, D. M., Furness, M. S., & Rice, K. C. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200112000-00003 · Cited by 45
Opioid Drugs: A Comparative Survey of Therapeutic and "Street" Use
Cowan, D. T., Allan, L. G., Libretto, S. E., & Griffiths, P. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.01026.x · Cited by 40
Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse
Madia, P. A., Dighe, S. V., SIROHI, S. K., Walker, E. A., & Yoburn, B. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1673-6 · Cited by 39
Hydromorphone efficacy and treatment protocol impact on tolerance and μ-opioid receptor regulation
Kumar, P., Sunkaraneni, S., SIROHI, S. K., Dighe, S. V., Walker, E. A., & Yoburn, B. C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.025 · Cited by 31
Cited by
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Self-citationSelective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., et al. (2021) · Neurology International · doi:10.3390/neurolint13030038 · Cited by 440
Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord
Kardon, A. P., Polgár, E., Hachisuka, J., Snyder, L. M., Cameron, D., Savage, S., Cai, X., Karnup, S., Fan, C. R., Hemenway, G. M., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.046 · Cited by 369
Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment
Comer, S. D., & Cahill, C. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.005 · Cited by 302
Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021) · JAMA · doi:10.1001/jama.2021.11013 · Cited by 273
Metadata
- Authors
- Morgan, M. M., & Christie, M. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 164
- Issue
- 4
- Pages
- 1322-1334
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1561275320
- Cited by
- 270
- References
- 118
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.